Abstract:Stroke, Volume 55, Issue Suppl_1, Page AWP20-AWP20, February 1, 2024. Importance:Tenecteplase use is more prevalent as the thrombolytic drug of choice for acute ischemic stroke, with results demonstrating its non-inferiority compared to alteplase. However, there is conflicting data regarding intracranial hemorrhage risk.Objective:To determine the rate of symptomatic intracranial hemorrhage in ischemic stroke patients after thrombolysis with either tenecteplase or alteplase.Design:Retrospective cohort study.Setting:15 Texas stroke centers.Participants:431 patients that were eligible for thrombolytic therapy, and received either tenecteplase or alteplase.Exposure:Data was collected 90 days before and after the stroke center changed from alteplase to tenecteplase.Main Outcomes:Primary endpoint was to compare the incidence of sICH according to SITS-MOST/ECASS-3 criteria in the alteplase and tenecteplase groups. Secondary endpoint included the radiographic pattern of hemorrhagic conversion according to the Heidelberg bleeding classification (HBC).Results:Median age was 62.94 for alteplase and 64.45 for tenecteplase, females represented half of each cohort:110 for alteplase and 117 for tenecteplase. Half of patients received alteplase (n=216), 174 (81%) received alteplase within 3 hours versus 176 (82%) for tenecteplase. Endovascular thrombectomy was attempted in 34 patients (15%) receiving alteplase versus 26 patients (12%) receiving tenecteplase. 7 patients in the alteplase group (3.2%) and 14 (6.5%) in the tenecteplase group had sICH, with an odds ratio of 1.44 (95% CI 0.60-3.43; P=0.41). A higher NIHSS score on arrival (1.06; 95% CI 1.0004-1.131; P=0.04) was a statistically significant predictor of sICH. A two-sample proportion test on tenecteplase produced a statistically significant increase in HBC class 3 (P=0.040) over alteplase.Conclusions and Relevance:An increased rate of sICH was observed with a statistically significant increase in HBC class 3 with tenecteplase administration compared to alteplase. Suggested mechanisms of bleeding are hemorrhagic conversion in clinically silent infarcts and contusions underlying the lesions. This suggests a potential need to reevaluate the criteria for tenecteplase administration. Larger studies are required to confirm this data.

Abstract WP152: Changes In Thrombus Fibrin Content By Time In Patients Undergoing Thrombectomy

Association between clot composition and stroke origin in mechanical thrombectomy patients: analysis of the Stroke Thromboembolism Registry of Imaging and Pathology

Microbleeds, Cerebral Hemorrhage, and Functional Outcome After Stroke Thrombolysis.

Abstract 162: Arterial Aspirate Derived Exosomes From Patients With Large Vessel Occlusion Are Associated With Increased Blood-brain Barrier Permeability, Decreased Endothelial Integrity As Well Poor Clinical And Radiographic Outcomes Following Mechanical Thrombectomy

How clot composition influences fibrinolysis in the acute phase of stroke: a proteomic study of cerebral thrombi

Thrombus Histology as It Relates to Mechanical Thrombectomy: A Meta-Analysis and Systematic Review

Relationship between thrombus composition and prognosis in patients with acute ischemic stroke undergoing mechanical thrombectomy

316 Acute Ischemic Stroke Presentation Labs and Imaging Can Be Used to Model Thrombus Proteomic Composition

Clot Composition Analysis as a Diagnostic Tool to Gain Insight into Ischemic Stroke Etiology: A Systematic Review

Alterations of Hemostatic Molecular Markers During Acute Large Vessel Occlusion Stroke

Thrombus histology does not predict stroke etiological subtype but influences recanalization

Histone content, and thus DNA content, is associated with differential in vitro lysis of acute ischemic stroke clots

Histopathologic analysis of extracted thrombi from deep venous thrombosis and pulmonary embolism: Mechanisms and timing

Abstract 1069: Novel Approaches Dissecting Human Thrombus Composition

Abstract WP304: Investigating Thrombus Architecture Using Spatial Transcriptomics

699 Immune Activation on Stroke Thrombus Proteome Associated With Failed First Pass Recanalization by Thrombectomy

MicroCT and Histological Analysis of Clot Composition in Acute Ischemic Stroke

Abstract TMP87: Thrombus Age in Ischemic Stroke With Atrial Fibrillation

Abstract TP159: The Effect Of Diabetes Mellitus On Thrombus Composition In Patients With Stroke

Abstract WP20: Hemorrhagic Conversion Patterns After Stroke Thrombolysis With Alteplase versus Tenecteplase Real-World Experience

Plasma protein alterations during human large vessel stroke: A controlled comparison study